Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria

Journal of Infectious Diseases

Volumn 182, Issue 3, 2000, Pages 895-901

  Kampmann, Beate ^a   Gaora, P O ^b   Snewin, Valerie A ^a   Gares, Marie Pierre ^a,c   Young, Douglas B ^a   Levin, Michael ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Nederlandse Organisatie voor Toegeposte Wetenschap Prevention and Health   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NEUTRALIZING ANTIBODY; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BLOOD; CELL FRACTIONATION; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC RECOMBINATION; GROWTH INHIBITION; HUMAN; HUMAN EXPERIMENT; MYCOBACTERIUM; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REPORTER GENE; TUBERCULIN TEST; VACCINATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; DNA, RECOMBINANT; GENES, REPORTER; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033823535     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315766     Document Type: Article

References (34)

1. Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic
2. The new tuberculosis
3. Global surveillance for antituberculosis-drug resistance, 1994-1997: World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance
4. Childhood tuberculosis and BCG vaccine
5. Variation in protection by BCG: Implications of and for heterologous immunity
6. Diagnostic standards and classification of tuberculosis
7. New tools for tuberculosis control: Do we really need them?
8. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
9. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: Role of reactive nitrogen intermediates
10. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
11. Disseminated tuberculosis in interferon gamma gene-disrupted mice
12. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
13. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
14. Major histocompatibility complex class-1 restricted T cells are required for resistance to Mycobacterium tuberculosis infection
15. Protective role of γ/δ T cells and α/β T cells in tuberculosis
16. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection
17. Partial interferon-γ receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis
18. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
19. Cytotoxic T cell responses to intracellular pathogens
20. Apoptosis, but not necrosis of infected monocytes coupled with killing of intracellular bacillus Calmette-Guerin
21. Gamma interferon activates human macrophages to become tumoricidal and leishmaniacidal but enhances replication of macrophage-associated mycobacteria
22. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival
23. Review: The immune response in human tuberculosis: Implications for tuberculosis control
24. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages
25. Luciferase in vivo expression technology: Use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice
26. Assessment of immunity to mycobacterial infection using luciferase reporter constructs
27. New use of BCG for recombinant vaccines
28. Epidemiology of tuberculosis
29. Monocyte antimycobacterial activity before and after Mycobacterium bovis BCG vaccination in Chingleput, India, and London, United Kingdom
30. Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis bacillus Calmette-Guerin: Evaluation with a mycobacterial reporter strain
31. + T cells in purified protein derivative-positive, but not in purified protein negative subjects
32. Mycobacterium tuberculosis bacteraemia in patients with and without human immunodeficiency virus infection
33. Unrecognised Mycobacterium tuberculosis bacteraemia among hospital patients in less developed countries
34. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence